Principal Investigator
Susanne Doblecki-Lewis
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20220882
Clinical Trial Summary
National Institute of Allergy and Infectious Diseases (NIAID)/ A Randomized, Placebo-Controlled, Double-Blinded Trial of the Safety and Efficacy of Tecovirimat for the Treatment of Human Monkeypox Virus Disease”
Phase
TBD
Funding Agency/Sponsor
Other
Disease
Other
Contact Information
Study Contact
Claudia Santos
Phone Number
+1 (305) 2439034
Email
csantos15@miami.edu